Poster Sessions > Poster Sessions Detail
Poster Sessions
CANCER-33 |
Wendy Westbroek |
|---|---|
W. Westbroek, D. Maynard, A. Hendrix, M.C. Seabra, O. De Wever, W.A. Gahl |
|
The Secretory Small GTPase Rab27B Regulates Invasive Tumor Growth and Metastasis through Extracellular HSP90α |
|
Key players in exocytic and endocytic trafficking include Rab GTPases. Our studies on various secretory Rab GTPases revealed that over-expression of Rab27B in several breast cancer cell lines promoted cell cycle progression, F-actin reorganization, and invasion into matrigel. By establishing MCF-7 cells that stably expressed wild type Rab27B, Rab27B-Q78L, Rab27B-T23N, and the geranylgeranyl mutant Rab27B-GER, we determined that Rab27B-mediated invasion was dependent on geranylation and GTP-binding state. Our xenograft mouse model showed that mice injected with MCF-7-Rab27B or Rab27B-Q78L developed invasive xenografts that were 8-fold larger than the non-invasive MCF-7-Rab27B-T23N or Rab27B-GER xenografts. Proteomic analysis of Rab27B-positive purified vesicles and the secretome of MCF-7 Rab27B identified HSP90α as a key pro-invasive factor. By ELISA and western blotting, we showed that HSP90α secretion was upregulated in the conditioned media prepared from MCF-7-Rab27B and Rab27B-Q78L. Treatment with an HSP90α neutralizing antibody reversed the invasive phenotype of MCF-7-Rab27B cells while a dose-dependent treatment with recombinant HSP90α of MCF-7 cells induced invasion. Finally, we examined endogenous Rab27B expression in 60 clinical samples derived from breast cancer patients by real time quantitative PCR and immune-histology. We showed that upregulation of endogenous Rab27B mRNA and protein correlated with lymph node metastasis, tumor grade and positive ER-status. |
|

